COMMUNIQUÉS West-GlobeNewswire

Monthly information related to total number of voting rights and shares composing the share capital – July 31, 2018

06/08/2018 - 07:30

Article 223-16 of general regulation of French Autorité des Marchés Financiers Lyon - France ERN France, Aug. 06, 2018 (GLOBE NEWSWIRE) -- Monthly information related to total number of voting rights and shares [...]

Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social – 31 juillet 2018

06/08/2018 - 07:30

Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers Lyon - France ERN France, 06 août 2018 (GLOBE NEWSWIRE) -- Information mensuelle relative au nombre total de droits de vote et d’actions composant [...]

Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

03/08/2018 - 22:30

BURLINGTON, Mass., Aug. 03, 2018 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced a grant of inducement stock options to six new employees for an aggregate of 14,800 shares of common stock. [...]

SeaSpine Reports Granting of Inducement Awards

03/08/2018 - 22:05

CARLSBAD, Calif., Aug. 03, 2018 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced [...]

GBT Announces New Employment Inducement Grants

03/08/2018 - 22:05

SOUTH SAN FRANCISCO, Calif., Aug. 03, 2018 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that, on August 1, 2018, the compensation committee of the Company’s board of directors [...]

EyePoint Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

03/08/2018 - 22:05

WATERTOWN, Mass., Aug. 03, 2018 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT), a specialty biopharmaceutical company committed to developing and commercializing innovative ophthalmic products, today [...]

Acer Therapeutics Announces Closing of Underwritten Public Offering

03/08/2018 - 22:01

NEWTON, Mass., Aug. 03, 2018 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and ultra-rare [...]

Advanced Proteome Therapeutics Announces Non-Brokered Private Placement

03/08/2018 - 22:00

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Aug. 03, 2018 (GLOBE NEWSWIRE) -- Advanced Proteome Therapeutics Corporation (“ APC ” or the “ [...]

California, Some Cities, Want to Ban Affordable Health Insurance, States the Association of American Physicians and Surgeons (AAPS)

03/08/2018 - 21:02

TUCSON, Ariz., Aug. 03, 2018 (GLOBE NEWSWIRE) -- The Trump Administration is liberalizing the rules to allow more people to have short-term, limited duration health insurance, but the rule is on a “crash course with a [...]

Melinta Therapeutics Announces Vabomere™ (meropenem and vaborbactam) Granted New Technology Add-On Payment by CMS

03/08/2018 - 19:31

Payment Will Reimburse up to 50% of Cost for Hospitals Treating Medicare Patients in Inpatient Setting NEW HAVEN, Conn., Aug. 03, 2018 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT), a commercial-stage [...]

OPKO Health Completes Enrollment in Global Phase 3 Study of Somatrogon (hGH-CTP) in Growth Hormone Deficient Children

03/08/2018 - 19:29

MIAMI, Aug. 03, 2018 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) has completed enrollment in the Company’s global pivotal Phase 3 study in growth hormone deficient children, evaluating a single weekly injection [...]

CompactCath élargit son portefeuille de produits en introduisant des nouvelles sondes urinaires intermittentes discrètes, droites et coudées

03/08/2018 - 19:18

Les produits apportent un soulagement bienvenu aux utilisateurs autonomes quotidiens de sondes urinaires PALO ALTO, Californie, 03 août 2018 (GLOBE NEWSWIRE) -- CompactCath ( www.compactcath.com ), un fournisseur d' [...]

Draft decisions Joint Stock Company „Olainfarm” extraordinary General Meeting of shareholders to be held on September 04th, 2018

03/08/2018 - 19:07

Draft decisions Joint Stock Company „Olainfarm” extraordinary General Meeting of shareholders to be held on September 04th, 2018 1. Amendment of Statutes. 1.1. Initiate following amendments to the Statutes of the Joint [...]

Announcement About Convening of the Extraordinary General Meeting of Shareholders of Joint Stock Company “Olainfarm”

03/08/2018 - 18:56

Announcement About Convening of the Extraordinary General Meeting of Shareholders Joint Stock Company “Olainfarm” Management Board of the Joint Stock Company “Olainfarm”, unitary registration number. 40003007246, [...]

Affimed Announces Second Quarter 2018 Financial Results and Corporate Update Conference Call

03/08/2018 - 18:26

Heidelberg, Germany, August 3, 2018 - Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies, today announced that on August [...]

BIONOVELUS ENTERS INTO SETTLEMENT AND MUTUAL RELEASE AGREEMENT AND RELATED STIPULATED JUDGMENT WITH L2 CAPITAL, LLC

03/08/2018 - 17:55

FOR IMMEDIATE RELEASE —Phoenix, Aug. 03, 2018 (GLOBE NEWSWIRE) -- — BioNovelus (OTC Pink: ONOV) (the “ Company ”) entered into a Claim Purchase Agreement on June 30, 2018 with L2 Capital, LLC (“ L2 ”) to make payments [...]

CompactCath Expands Product Portfolio with New Discreet Straight and Coudé Intermittent Catheters

03/08/2018 - 15:00

Products welcome added relief for everyday self-catheterizing users PALO ALTO, Calif., Aug. 03, 2018 (GLOBE NEWSWIRE) -- CompactCath ( www.compactcath.com ), a medical device company committed to improving the quality [...]

Lexaria’s DehydraTECH Triples Bioavailability of CBD in Human Trial -- CFN Media

03/08/2018 - 15:00

SEATTLE, Aug. 03, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, today announced publication of an article [...]

La Jolla Pharmaceutical Company Announces Receipt of New Technology Add-on Payment Coverage for GIAPREZA

03/08/2018 - 15:00

SAN DIEGO, Aug. 03, 2018 (GLOBE NEWSWIRE) -- La Jolla Pharmaceutical Company (Nasdaq: LJPC), a leader in the discovery, development and commercialization of innovative therapies intended to significantly improve [...]